insights_auto
Why is MGX down 6.19%?
Dive Deeperchevron_right
MGX:NASDAQ
Metagenomi Therapeutics Inc
$ 1.06
arrow_downward
-6.19%(-0.070) 1D
$ 1.12
arrow_upward
+5.66% (+0.060)bedtimeAfter hours
Closed: 9-р сарын 30, 16:00:01 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MGX...
Open
$ 1.13
High
$ 1.14
Low
$ 1.06
Mkt. cap
40.04 сая
Avg. vol.
150.69 мян
Volume
152.29 мян
52-wk high
$ 3.95
52-wk low
$ 1.06
EPS
-$ 2.49
Shares outstanding
37.78 сая
No. of employees
113
Open
$ 1.13
High
$ 1.14
Low
$ 1.06
Mkt. cap
40.04 сая
Avg. vol.
150.69 мян
Volume
152.29 мян
52-wk high
$ 3.95
52-wk low
$ 1.06
EPS
-$ 2.49
Shares outstanding
37.78 сая
No. of employees
113
News stories
From web sources and news partners
Simply Wall Street
·
31 минутын өмнө
Is NetApp (NTAP) Becoming More Central To AI Infrastructure With Novus?
Kalkine Media
·
1 цагийн өмнө
BVF Partners Reveals 5.6% Ownership Stake in Stoke Therapeutics Inc. (NASDAQ:STOK)
Barchart.com
·
1 цагийн өмнө
What You Need To Know Ahead of Nasdaq's Earnings Release
Yahoo Finance
·
6 цагийн өмнө
Blood Cancer United Rings Nasdaq Closing Bell to Celebrate More Time for Patients
About Metagenomi Therapeutics Inc
CEO-
Employees113
Founded2016
HeadquartersEmeryville, Калифорни, Америкийн Нэгдсэн Улс
Sector-
Websitemetagenomi.co